Prostatis Group’s Panagram AAA CLO ETF CLOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$616K Buy
24,086
+296
+1% +$7.56K 0.16% 95
2025
Q4
$607K Buy
23,790
+7,258
+44% +$185K 0.14% 95
2025
Q3
$423K Buy
16,532
+7,555
+84% +$193K 0.11% 106
2025
Q2
$230K Buy
+8,977
New +$228K 0.07% 147

Other funds holding CLOX

Prostatis Group's CLOX Position: Q1 2026 in Review

Prostatis Group increased its Panagram AAA CLO ETF (CLOX) stake by 1.2% in Q1 2026, buying an estimated $7.56K and bringing the position to 24,086 shares worth $616K. The position accounts for 0.16% of the portfolio, ranked #95.

Prostatis Group first reported a position in CLOX in Q2 2025 and has held it in 4 quarters since. 53 funds tracked by Wall St. Rank hold CLOX as of Q1 2026.

  • Prostatis Group held 24,086 shares of Panagram AAA CLO ETF worth $616K as of Q1 2026.
  • Prostatis Group bought 296 Panagram AAA CLO ETF shares in Q1 2026, an estimated $7.56K.
  • Panagram AAA CLO ETF made up 0.16% of Prostatis Group's portfolio in Q1 2026, its #95 holding.
  • Prostatis Group first reported a position in Panagram AAA CLO ETF in Q2 2025 and has held it in 4 quarters since.
  • 53 funds tracked by Wall St. Rank held Panagram AAA CLO ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.